Boehringer biopharmaceuticals China receives approval supply EU and US
Boehringer Ingelheim Biopharmaceuticals China receives approval for supply of EU and US markets
Search
New Therapeutic Antibody Discovery Collaboration
Proprietary antibody libraries to help discover therapeutic antibodies against multiple targets
biolabs-heidelberg
Boehringer Ingelheim supports the launch of BioLabs first European Location in Heidelberg.
Boehringer expands production site in Greece
Boehringer expands production site in Greece for new medicine
Sites Around the World
Sites Around the World
Really Digital, Mr Hach!
The Head of User Experience and SCRUM at Boehringer Ingelheim’s digital lab BI X offers a glimpse into his work and motivation.
IT at BI
Discover firsthand what IT does at BI #IdoIT
Pascal Haubert
Three months into an internship with us, Pascal Haubert talks about responsibility, learning, and mutual support.
Karla Alvarez
Karla Alverez: ways to learn and grow
Andreas Lenk
Andreas Lenk: driven to make a difference
Albert Paul
Albert Paul: driven to make a difference
Eva-Maria Wlaschitz
Eva-Maria Wlaschitz: ways to learn and grow
Roasted Eggplant Fan Video
Find out how this simple plant-based meal from Taking Cancer on Through Flavour and Taste Life are made
tomato_and_carrot_soup.pdf
Glutamate receptor modulator
Glutamate receptor modulator
Glutamate receptor modulator
More Than Scleroderma
A hub of knowledge, advice and support for those whose lives have been touched by scleroderma.
Telemedicine – the standalone study that became the new normal
Dr Vijay Prabhakar tells us how a remote healing project made him a pandemic pioneer.Read it now!
The impact of carbon reduction projects
Boehringer Ingelheim voluntarily contributes to carbon reduction projects that benefit sustainable development.
Technologies
We are expanding our global network of technology partners Learn more about partnering with us.
The power of patient advocacy in cancer care
Larry, a retired US Navy veteran, and Jeff, UICC President, have more in common than a cancer diagnosis: they share a passion for patient empowerment.
FDA- HFpEF-breakthrough-designation-EMPEROR-preserved
U.S. FDA issues Breakthrough Therapy Designation for the treatment of adults with heart failure with preserved ejection fraction
Stroke Prevention in AF
Stroke Prevention in AF
CHMP_opinion_nintedanib_ILD_PF
Nintedanib received a CHMP positive opinion for the treatment of patients with other chronic fibrosing ILDs with a progressive phenotype beyond IPF
The Boehringer Ingelheim Veterinary Scholars Program
The aim of the Boehringer Ingelheim Veterinary Scholars Program is to expose students to biomedical research